Logo image of WAY

WAYSTAR HOLDING CORP (WAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:WAY - US9467841055 - Common Stock

32.75 USD
-0.23 (-0.7%)
Last: 12/31/2025, 8:00:02 PM
32.75 USD
0 (0%)
After Hours: 12/31/2025, 8:00:02 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to WAY. WAY was compared to 35 industry peers in the Health Care Technology industry. WAY has an average financial health and profitability rating. WAY is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

WAY had positive earnings in the past year.
In the past year WAY had a positive cash flow from operations.
WAY Yearly Net Income VS EBIT VS OCF VS FCFWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

With an excellent Return On Assets value of 2.34%, WAY belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
With an excellent Return On Equity value of 3.45%, WAY belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
WAY has a better Return On Invested Capital (4.19%) than 74.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for WAY is below the industry average of 6.61%.
The last Return On Invested Capital (4.19%) for WAY is above the 3 year average (2.09%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROIC 4.19%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
WAY Yearly ROA, ROE, ROICWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 1 -1 2 -2

1.3 Margins

The Profit Margin of WAY (10.69%) is better than 94.29% of its industry peers.
Looking at the Operating Margin, with a value of 23.41%, WAY belongs to the top of the industry, outperforming 94.29% of the companies in the same industry.
WAY's Operating Margin has improved in the last couple of years.
WAY has a Gross Margin of 67.78%. This is in the better half of the industry: WAY outperforms 65.71% of its industry peers.
In the last couple of years the Gross Margin of WAY has declined.
Industry RankSector Rank
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
WAY Yearly Profit, Operating, Gross MarginsWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WAY is destroying value.
WAY has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WAY has an improved debt to assets ratio.
WAY Yearly Shares OutstandingWAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M
WAY Yearly Total Debt VS Total AssetsWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

WAY has an Altman-Z score of 2.93. This is not the best score and indicates that WAY is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of WAY (2.93) is better than 65.71% of its industry peers.
The Debt to FCF ratio of WAY is 4.35, which is a neutral value as it means it would take WAY, 4.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.35, WAY is in the better half of the industry, outperforming 65.71% of the companies in the same industry.
A Debt/Equity ratio of 0.38 indicates that WAY is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, WAY is doing worse than 68.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Altman-Z 2.93
ROIC/WACC0.44
WACC9.55%
WAY Yearly LT Debt VS Equity VS FCFWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 3.89 indicates that WAY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.89, WAY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
WAY has a Quick Ratio of 3.89. This indicates that WAY is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.89, WAY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.89
Quick Ratio 3.89
WAY Yearly Current Assets VS Current LiabilitesWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 272.54% over the past year.
Looking at the last year, WAY shows a quite strong growth in Revenue. The Revenue has grown by 14.75% in the last year.
The Revenue has been growing by 17.71% on average over the past years. This is quite good.
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%

3.2 Future

WAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.38% yearly.
The Revenue is expected to grow by 12.62% on average over the next years. This is quite good.
EPS Next Y366.15%
EPS Next 2Y128.88%
EPS Next 3Y80.5%
EPS Next 5Y52.38%
Revenue Next Year17%
Revenue Next 2Y17.22%
Revenue Next 3Y15%
Revenue Next 5Y12.62%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
WAY Yearly Revenue VS EstimatesWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
WAY Yearly EPS VS EstimatesWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

WAY is valuated rather expensively with a Price/Earnings ratio of 24.44.
Compared to the rest of the industry, the Price/Earnings ratio of WAY indicates a rather cheap valuation: WAY is cheaper than 82.86% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. WAY is around the same levels.
WAY is valuated rather expensively with a Price/Forward Earnings ratio of 19.71.
80.00% of the companies in the same industry are more expensive than WAY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.13. WAY is around the same levels.
Industry RankSector Rank
PE 24.44
Fwd PE 19.71
WAY Price Earnings VS Forward Price EarningsWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WAY indicates a somewhat cheap valuation: WAY is cheaper than 71.43% of the companies listed in the same industry.
WAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WAY is cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.02
EV/EBITDA 18.56
WAY Per share dataWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of WAY may justify a higher PE ratio.
WAY's earnings are expected to grow with 80.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y128.88%
EPS Next 3Y80.5%

0

5. Dividend

5.1 Amount

WAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

WAYSTAR HOLDING CORP

NASDAQ:WAY (12/31/2025, 8:00:02 PM)

After market: 32.75 0 (0%)

32.75

-0.23 (-0.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-16 2026-02-16
Inst Owners79.78%
Inst Owner Change29.3%
Ins Owners1.91%
Ins Owner Change-0.53%
Market Cap6.27B
Revenue(TTM)1.04B
Net Income(TTM)111.18M
Analysts84.17
Price Target49.12 (49.98%)
Short Float %6.1%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.35%
Min EPS beat(2)4.39%
Max EPS beat(2)6.31%
EPS beat(4)3
Avg EPS beat(4)28.35%
Min EPS beat(4)-1.27%
Max EPS beat(4)103.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)3.6%
Max Revenue beat(2)3.95%
Revenue beat(4)4
Avg Revenue beat(4)3.51%
Min Revenue beat(4)2.36%
Max Revenue beat(4)4.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.77%
PT rev (3m)-3.24%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)13.43%
EPS NY rev (1m)2.1%
EPS NY rev (3m)5.27%
Revenue NQ rev (1m)0.72%
Revenue NQ rev (3m)14.53%
Revenue NY rev (1m)1.19%
Revenue NY rev (3m)4.76%
Valuation
Industry RankSector Rank
PE 24.44
Fwd PE 19.71
P/S 6.03
P/FCF 22.02
P/OCF 20.36
P/B 1.94
P/tB N/A
EV/EBITDA 18.56
EPS(TTM)1.34
EY4.09%
EPS(NY)1.66
Fwd EY5.07%
FCF(TTM)1.49
FCFY4.54%
OCF(TTM)1.61
OCFY4.91%
SpS5.44
BVpS16.84
TBVpS-3.93
PEG (NY)0.07
PEG (5Y)N/A
Graham Number22.54
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.45%
ROCE 5.3%
ROIC 4.19%
ROICexc 4.61%
ROICexgc 99.81%
OM 23.41%
PM (TTM) 10.69%
GM 67.78%
FCFM 27.36%
ROA(3y)-0.88%
ROA(5y)N/A
ROE(3y)-1.85%
ROE(5y)N/A
ROIC(3y)2.09%
ROIC(5y)N/A
ROICexc(3y)2.13%
ROICexc(5y)N/A
ROICexgc(3y)47.51%
ROICexgc(5y)N/A
ROCE(3y)2.64%
ROCE(5y)N/A
ROICexgc growth 3Y7.56%
ROICexgc growth 5YN/A
ROICexc growth 3Y30.65%
ROICexc growth 5YN/A
OM growth 3Y7.95%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.38%
GM growth 5YN/A
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.35
Debt/EBITDA 3.21
Cap/Depr 16.87%
Cap/Sales 2.24%
Interest Coverage 250
Cash Conversion 80.68%
Profit Quality 255.91%
Current Ratio 3.89
Quick Ratio 3.89
Altman-Z 2.93
F-Score8
WACC9.55%
ROIC/WACC0.44
Cap/Depr(3y)12.11%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)272.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%164.29%
EPS Next Y366.15%
EPS Next 2Y128.88%
EPS Next 3Y80.5%
EPS Next 5Y52.38%
Revenue 1Y (TTM)14.75%
Revenue growth 3Y17.71%
Revenue growth 5YN/A
Sales Q2Q%11.89%
Revenue Next Year17%
Revenue Next 2Y17.22%
Revenue Next 3Y15%
Revenue Next 5Y12.62%
EBIT growth 1Y124.84%
EBIT growth 3Y27.06%
EBIT growth 5YN/A
EBIT Next Year150.61%
EBIT Next 3Y48.39%
EBIT Next 5Y31.75%
FCF growth 1Y375.9%
FCF growth 3Y15.76%
FCF growth 5YN/A
OCF growth 1Y229.9%
OCF growth 3Y16.85%
OCF growth 5YN/A

WAYSTAR HOLDING CORP / WAY FAQ

What is the fundamental rating for WAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to WAY.


What is the valuation status of WAYSTAR HOLDING CORP (WAY) stock?

ChartMill assigns a valuation rating of 6 / 10 to WAYSTAR HOLDING CORP (WAY). This can be considered as Fairly Valued.


Can you provide the profitability details for WAYSTAR HOLDING CORP?

WAYSTAR HOLDING CORP (WAY) has a profitability rating of 6 / 10.


How financially healthy is WAYSTAR HOLDING CORP?

The financial health rating of WAYSTAR HOLDING CORP (WAY) is 6 / 10.


What is the expected EPS growth for WAYSTAR HOLDING CORP (WAY) stock?

The Earnings per Share (EPS) of WAYSTAR HOLDING CORP (WAY) is expected to grow by 366.15% in the next year.